Dasatinib
- Product NDC
- 0480-5103
- 11-digit product format
- 004805103
- Labeler code
- 0480
- Product ID
- 0480-5103_4f8ca317-4225-4d8f-b028-836e1dd07fe1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dasatinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals, Inc.
- Application
- ANDA211094
- Marketing category
- ANDA
- Marketing start
- 2025-09-18
- Substance
- DASATINIB
- Active strength
- 70 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| RBZ1571X5H | DASATINIB | 863127-77-9 | DASATINIB |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 0480-5103-06 | 00480510306 | 60 TABLET, FILM COATED in 1 BOTTLE (0480-5103-06) | 2025-09-18 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Dasatinib | AvKARE | 2025-11-18 | HUMAN PRESCRIPTION DRUG LABEL | 1 |
| Dasatinib | Teva Pharmaceuticals, Inc. | 2024-08-31 | HUMAN PRESCRIPTION DRUG LABEL | 4 |